Results for tag: atezolizumab Total Items Found: 24

Peter Galle on Patient-Reported Outcomes for Atezolizumab/Bevacizumab vs Sorafenib in HCC

Type of Page:TapVideo
Edit This Item
Tags for this item:
gi cancers symposium
PROs
patient-reported outcomes
atezolizumab
bevacizumab
sorafenib
immunotherapy
unresectable
HCC
liver cancer
hepatocellular carcinoma

Created: 1/28/2020 9:06:50 PM

Hope Rugo on a Retrospective Analysis of PD-L1 Immunohistochemistry Assays

Type of Page:TapVideo
Edit This Item
Tags for this item:
san antonio breast cancer symposium
assays
immunohistochemistry
pd-l1
breast cancer
tnbc
triple-negative breast cancer
atezolizumab
nab-paclitaxel

Created: 1/13/2020 10:42:08 PM

Luca Gianni on the Neoadjuvant Treatment of Triple-Negative Breast Cancer

Type of Page:TapVideo
Edit This Item
Tags for this item:
san antonio breast
neoadjuvant therapy
neotrip
pcr
atezolizumab
immunotherapy
tnbc
breast cancer
high-risk breast cancer

Created: 12/13/2019 11:38:11 PM

Thomas Powles and Enrique Grande on Atezolizumab and Platinum-Based Chemotherapy for Urothelial Carcinoma

Type of Page:TapVideo
Edit This Item
Tags for this item:
atezolizumab
bladder cancer
chemotherapy
esmo
immunotherapy
imvigor130
urothelial carcinoma

Created: 10/1/2019 7:10:51 AM

Ana Maria Arance Fernandez on Cobimetinib/Atezolizumab vs Pembrolizumab in Melanoma

Type of Page:TapVideo
Edit This Item
Tags for this item:
esmo
imspire170
pembrolizumab
atezolizumab
braf v600
cobimetinib
immunotherapy
melanoma
skin cancer
wild-type

Created: 9/30/2019 2:14:55 PM

Sherene Loi and Leisha Emens on Atezolizumab/Trastuzumab Emtansine for HER2-Positive Breast Cancer

Type of Page:TapVideo
Edit This Item
Tags for this item:
esmo
trastuzumab emtansine
atezolizumab
breast cancer
her2-positive
kate2
overall survival
second-line therapy
t-dm1
esmo
trastuzumab emtansine
atezolizumab
breast cancer
HER2-positive
kate2
overall survival
second-line therapy
T-DM1

Created: 9/29/2019 5:25:15 PM

Peter Schmid and Hope Rugo on IMpassion130

Type of Page:TapVideo
Edit This Item
Tags for this item:
asco 2019
atezolizumab
IMpassion 130
nab-paclitaxel
overall survival analysis
triple-negative breast cancer

Created: 6/13/2019 4:16:22 PM

David Kwiatkowski on Neoadjuvant Immunotherapy for Resectable NSCLC

Type of Page:TapVideo
Edit This Item
Tags for this item:
lung cancer
nsclc
asco 2019
atezolizumab
immunotherapy
neoadjuvant therapy

Created: 6/2/2019 9:14:02 PM

Kamran Ahmed on SBRT Plus Atezolizumab in Cervical Cancer

Type of Page:TapVideo
Edit This Item
Tags for this item:
sbrt
asco 2019
atezolizumab
cervical cancer
hypofractioned radiotherapy
stereotactic body radiotherapy

Created: 6/1/2019 6:59:54 PM

Elizabeth Mittendorf on Breast Cancer Immunotherapy

Type of Page:TapVideo
Edit This Item
Tags for this item:
immune checkpoint inhibitors
asco sitc
atezolizumab
breast cancer
immunotherapy
nab-paclitaxel
targeted treatment
triple-negative breast cancer

Created: 3/5/2019 5:56:07 PM

Rana McKay on Results From a Trial on Atezolizumab and Bevacizumab

Type of Page:TapVideo
Edit This Item
Tags for this item:
Genitourinary Cancers Symposium
atezolizumab
bevacizumab
clear cell
non-clear cell renal cancer
renal cell carcinoma
sarcomatoid

Created: 2/21/2019 2:59:35 AM

Lisa Carey and Sherene Loi on IMpassion 130 in TNBC

Type of Page:TapVideo
Edit This Item
Tags for this item:
ESMO 2018
IMpassion 130
breast cancer
metastatic
triple-negative breast cancer
nab-paclitaxel
atezolizumab
immunotherapy

Created: 10/21/2018 10:35:57 AM

Bernard Escudier on the IMmotion151 Trial

Type of Page:TapVideo
Edit This Item
Tags for this item:
ASCO 2018
RCC
renal cell carcinoma
IMmotion 151
kidney cancer
atezolizumab
patient-reported outcomes
bevacizumab
sunitinib
treatment-naive

Created: 6/4/2018 7:36:38 PM

Robert Jotte on NSCLC Results From the IMpower131 Trial

Type of Page:TapVideo
Edit This Item
Tags for this item:
ASCO 2018
NSCLC
lung cancer
IMpower131 trial
atezolizumab
carboplatin
paclitaxel
nab-paclitaxel
first-line therapy
squamous

Created: 6/2/2018 5:56:01 PM

Gregory R. Pond, PhD, on Urothelial Cancer: Advance in Prognosis

Type of Page:TapVideo
Edit This Item
Tags for this item:
Genitourinary Cancers Symposium
genitourinary cancer
bladder cancer
urothelial carcinoma
prognostic model
postplatinum
atezolizumab

Created: 2/12/2018 8:34:57 PM

Sumanta K. Pal, MD, on RCC: Results From Two Clinical Trials

Type of Page:TapVideo
Edit This Item
Tags for this item:
Genitourinary Cancers Symposium
genitourinary cancer
RCC
renal cell carcinoma
kidney cancer
IMmotion 151
atezolizumab
bevacizumab
sunitinib
axitinib
pembrolizumab

Created: 2/12/2018 8:17:15 PM

Thomas Powles, MD, on Urothelial Carcinoma: Results From the IMvigor211 Trial

Type of Page:TapVideo
Edit This Item
Tags for this item:
Genitourinary Cancers Symposium
genitourinary cancer
urothelial cancer
bladder cancer
IMvigor 211
atezolizumab
chemotherapy
immune biomarker
tumor mutational burden

Created: 2/12/2018 7:50:57 PM

Primo Lara, MD, on RCC: Expert Perspective on Three Key Papers

Type of Page:TapVideo
Edit This Item
Tags for this item:
ASCO 2017
Primo Lara
UC Davis
renal cell carcinoma
kindly cancer
epacadostat
pembrolizumab
atezolizumab
bevacizumab
sunitinib
pazopanib

Created: 6/5/2017 11:53:44 AM

Toni K. Choueiri, MD, on Untreated RCC: Phase II Trial Results

Type of Page:TapVideo
Edit This Item
Tags for this item:
GU Cancers Symposium 2017
Toni Choueiri
Dana-Farber
kidney cancer
untreated RCC
renal cell carcinoma
atezolizumab
bevacizumab
sunitinib

Created: 2/21/2017 2:31:07 PM

Fabrice Barlesi, MD, PhD, on NSCLC: Results From the OAK Trial (French Language Version)

Type of Page:TapVideo
Edit This Item
Tags for this item:
ESMO 2016
Fabrice Barlesi
Aix Marseille University
Assistance Publique Hopitaux De
atezolizumab
docetaxel
NSCLC
lung cancer
OAK trial
non-small cell lung cancer

Created: 10/12/2016 3:31:31 AM

Fabrice Barlesi, MD, PhD, on NSCLC: Results From the OAK Trial

Type of Page:TapVideo
Edit This Item
Tags for this item:
ESMO 2016
Fabrice Barlesi
Aix Marseille University
atezolizumab
docetaxel
NSCLC
lung cancer
OAK trial
non-small cell lung cancer

Created: 10/10/2016 11:07:32 AM

Jonathan E. Rosenberg, MD, and Toni K. Choueiri, MD, on Bladder Cancer: Mutation Burden and Atezolizumab

Type of Page:TapVideo
Edit This Item
Tags for this item:
ASCO 2016
Toni Choueiri
Dana-Farber
Jonathan Rosenberg
Memorial Sloan Kettering
bladder cancer
mutation burden
atezolizumab
PD-L1 immunotherapy
progression-free survival
overall survival
intrinsic expression subtype

Created: 6/8/2016 9:55:45 AM

Arjun Vasant Balar, MD, on Urothelial Carcinoma: Analysis of the IMvigor210 Cohort 1

Type of Page:TapVideo
Edit This Item
Tags for this item:
ASCO 2016
Arjun Vasant Balar
urothelial carcinoma
NYU Perlmutter Cancer Center
bladder cancer
atezolizumab
IMvigor210 trial
cisplatin-ineligible
metastatic urothelial carcinoma

Created: 6/6/2016 1:15:59 PM

Jonathan E. Rosenberg, MD, on Results of the IMvigor 210 Study on Atezolizumab in Locally Advanced or Metastatic Urothelial Cancer

Type of Page:TapVideo
Edit This Item
Tags for this item:
ECC 2015
Jonathan Rosenberg
Memorial Sloan Kettering
MSKCC
IMvigor
PDL1
bladder cancer
urothelial
atezolizumab
platinum chemotherapy

Created: 1/31/2016 12:41:22 AM
Order By Item Count
Order Alphabetically